9,10-dimethyl-1,2-benzanthracene and lfm a13

9,10-dimethyl-1,2-benzanthracene has been researched along with lfm a13 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Orhan, C; Ozercan, IH; Sahin, K; Sahin, N; Tuzcu, M; Yabas, M	1

Other Studies

1 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and lfm a13

Article	Year
LFM-A13, a potent inhibitor of polo-like kinase, inhibits breast carcinogenesis by suppressing proliferation activity and inducing apoptosis in breast tumors of mice. Investigational new drugs, 2018, Volume: 36, Issue:3 Topics: 9,10-Dimethyl-1,2-benzanthracene; Amides; Animals; Apoptosis; Carcinogenesis; Cell Cycle; Cell Cycle Proteins; Cell Proliferation; Cell Survival; Female; Humans; Mammary Neoplasms, Animal; Mice, Inbred BALB C; Nitriles; Paclitaxel; Polo-Like Kinase 1; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Rats; Survival Analysis	2018

Article

Year

LFM-A13, a potent inhibitor of polo-like kinase, inhibits breast carcinogenesis by suppressing proliferation activity and inducing apoptosis in breast tumors of mice.

Investigational new drugs, 2018, Volume: 36, Issue:3

Topics: 9,10-Dimethyl-1,2-benzanthracene; Amides; Animals; Apoptosis; Carcinogenesis; Cell Cycle; Cell Cycle Proteins; Cell Proliferation; Cell Survival; Female; Humans; Mammary Neoplasms, Animal; Mice, Inbred BALB C; Nitriles; Paclitaxel; Polo-Like Kinase 1; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Rats; Survival Analysis

2018